$80,000 of ZOETIS lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to animal health; issues related to trade; issues related to tax; issues pertaining to the Farm Bill; and issues pertaining to H.R. 1842-PAW Act."
You can find more data on corporate lobbying on Quiver Quantitative.
ZTS Congressional Stock Trading
Members of Congress have traded $ZTS stock 5 times in the past 6 months. Of those trades, 4 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ZTS stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 2 purchases worth up to $30,000 on 09/18, 06/16 and 1 sale worth up to $15,000 on 07/17.
- REPRESENTATIVE BYRON DONALDS has traded it 2 times. They made 2 purchases worth up to $30,000 on 06/09 and 0 sales.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
ZTS Insider Trading Activity
ZTS insiders have traded $ZTS stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $ZTS stock by insiders over the last 6 months:
- FRANK A DAMELIO purchased 6,650 shares for an estimated $501,343
- PAUL BISARO purchased 2,000 shares for an estimated $151,750
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
ZTS Hedge Fund Activity
We have seen 636 institutional investors add shares of ZTS stock to their portfolio, and 917 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MORGAN STANLEY removed 5,266,886 shares (-37.2%) from their portfolio in Q2 2026, for an estimated $378,478,427
- FLOSSBACH VON STORCH SE added 4,210,978 shares (+inf%) to their portfolio in Q2 2026, for an estimated $302,600,879
- BROWN ADVISORY INC removed 4,129,857 shares (-98.6%) from their portfolio in Q2 2026, for an estimated $296,771,524
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 4,003,981 shares (+inf%) to their portfolio in Q2 2026, for an estimated $287,726,074
- POLEN CAPITAL MANAGEMENT LLC removed 3,902,656 shares (-92.4%) from their portfolio in Q2 2026, for an estimated $280,444,860
- FUNDSMITH LLP removed 3,877,559 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $278,641,389
- BLACKROCK, INC. added 3,845,869 shares (+10.8%) to their portfolio in Q2 2026, for an estimated $276,364,146
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
ZTS Analyst Ratings
Wall Street analysts have issued reports on $ZTS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HSBC issued a "Buy" rating on 07/06/2026
To track analyst ratings and price targets for ZTS, check out Quiver Quantitative's $ZTS forecast page.
ZTS Price Targets
Multiple analysts have issued price targets for $ZTS recently. We have seen 7 analysts offer price targets for $ZTS in the last 6 months, with a median target of $99.0.
Here are some recent targets:
- Rajesh Kumar from HSBC set a target price of $95.0 on 07/06/2026
- Glen Santangelo from Barclays set a target price of $85.0 on 07/01/2026
- Steve Scala from TD Cowen set a target price of $104.0 on 06/30/2026
- Jonathan Block from Stifel set a target price of $85.0 on 06/26/2026
- Daniel Grosslight from Citigroup set a target price of $112.0 on 05/18/2026
- Chris Schott from JP Morgan set a target price of $130.0 on 05/08/2026
- Andrea Alfonso from UBS set a target price of $99.0 on 05/08/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
